Longevity Metrics AI/ML Development Study
Key claim: Longevity Metrics is building AI models that score functional tests from video, impute missing screening results, and predict clinical judgment and life expectancy, aiming to replace most in-person longevity screening with short video clips.
Abstract
This study builds AI models that score diagnostic screening tests, and that predict screening results, clinical judgment, and life expectancy. Longevity Metrics collects a battery of clinical tests on each participant, in whole or in part, and follows every participant for life.
The sit-to-rise test and the timed walk are scored by hand today, from a person’s count. A model scores the same test from video instead. It also measures what no one can count by eye - speed, asymmetry, steadiness - so one capture yields both the original score and additional measurements, intended to enrich the model and strengthen what it predicts.
Every test in a participant’s record measures the same body, so the tests are correlated: a test that was performed carries information about one that was not. A model trained across the library learns those relationships and estimates a missing result from the results that are present. Each estimate is checked against records where that part was actually measured, and over decades against death and disease through linkage to the 100-Year Human Aging Study (NCT07563777).
The hypothesis is that the full battery can eventually be predicted across modalities with high accuracy using a few short video clips, replacing most in-person screening. That would let preventive screening reach people and places a physical laboratory cannot. How far the input can be reduced is the question this study exists to answer.
Every model is a physician-reviewed clinical decision aid until it is cleared by the FDA.
Why this matters
Longevity Metrics extends the AI-in-longevity trend from drug discovery and wearables into the assessment layer itself — proposing that a short video clip plus imputation can stand in for an in-person functional screening battery. If it holds up, it reshapes who can be ‘screened’ and how cheaply; until outcome validation lands, it is a measurement-tooling claim built on an observational cohort, not a demonstrated predictor of healthspan.